Green Valley Pharmaceutical

Novel Drug Treatment Shows Improved Cognition in a Phase 3 Clinical Trial in Persons with Mild-to-Moderate Alzheimer’s Disease in China

admin

Leave a comment

Your email address will not be published. Required fields are marked *